posted on 2022-01-25, 05:16authored byDouglas L. Fink, James Cai, Matthew V. X. Whelan, Christopher Monit, Carlos Maluquer de Motes, Greg J. Towers, Rebecca P. Sumner
Additional file 1: Figure S1. Vpx is a broad antagonist of NF-κB. Figure S2. Inhibition of NF-κB is conserved amongst Vpx species variants.
Funding
Wellcome Trust FP7 Ideas: European Research Council Biotechnology and Biological Sciences Research Council